Wrinkle-Free wonder? small study tests microtox for skin smoothness
NCT ID NCT06604832
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 trial tested whether injecting a botulinum toxin (prabotulinumtoxinA-xvfs, also known as Jeuveau) into the forehead can improve facial skin quality, fine wrinkles, and texture. Twenty women with mild to moderate wrinkles received the treatment on one side of their face and either a placebo or a different toxin on the other side. Doctors rated skin changes using a scientific scale and an aesthetic improvement scale over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PrabotulinumtoxinA-xvfs (Jeuveau)
What this could lead to
If it works, this could point toward a cosmetic treatment for fine wrinkles and skin texture improvement.
What could go wrong
This is a very small, early-phase trial with only 20 participants, so results may not apply to everyone. The study is also completed, so no further development is planned.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN WRINKLING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
K. Kay Durairaj, MD, A Medical Corp.
Pasadena, California, 91105, United States